Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium-Glucose CoTransporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production

NCT03852901 is registered in ClinicalTrials.gov with National Institute on Aging (NIA) as lead sponsor.

NCT NCT03852901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03852901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium-Glucose CoTransporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production
Lead sponsor
National Institute on Aging (NIA)
Phase
Phase 1
Overall status
Completed
Start date
March 28, 2019
Completion date
December 13, 2021
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

empaglifozin, hypoglycemic agents, physiological effects of drugs, sodium-glucose transporter 2 inhibitors